pubmed-article:8976503 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8976503 | lifeskim:mentions | umls-concept:C0025663 | lld:lifeskim |
pubmed-article:8976503 | lifeskim:mentions | umls-concept:C0040132 | lld:lifeskim |
pubmed-article:8976503 | lifeskim:mentions | umls-concept:C0007589 | lld:lifeskim |
pubmed-article:8976503 | lifeskim:mentions | umls-concept:C0205615 | lld:lifeskim |
pubmed-article:8976503 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:8976503 | lifeskim:mentions | umls-concept:C0034606 | lld:lifeskim |
pubmed-article:8976503 | lifeskim:mentions | umls-concept:C1523987 | lld:lifeskim |
pubmed-article:8976503 | lifeskim:mentions | umls-concept:C0211492 | lld:lifeskim |
pubmed-article:8976503 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:8976503 | pubmed:dateCreated | 1997-1-23 | lld:pubmed |
pubmed-article:8976503 | pubmed:abstractText | The usefulness of the myocardial perfusion agent, Tc-99m-tetrofosmin (Myoview) in the follow-up of differentiated thyroid carcinoma was evaluated in a clinical study of 15 patients, primary treated with thyroidectomy and high-dose I-131-therapy (2960-3700 MBq). 12 with suspected recurrence and metastases and three patients without any suspicion and compared with other non-specific tracers like TI-201 and Tc-99m-sestamibi. | lld:pubmed |
pubmed-article:8976503 | pubmed:language | eng | lld:pubmed |
pubmed-article:8976503 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8976503 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8976503 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8976503 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8976503 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8976503 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8976503 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8976503 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8976503 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8976503 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8976503 | pubmed:month | Dec | lld:pubmed |
pubmed-article:8976503 | pubmed:issn | 0029-5566 | lld:pubmed |
pubmed-article:8976503 | pubmed:author | pubmed-author:LineWW | lld:pubmed |
pubmed-article:8976503 | pubmed:author | pubmed-author:GomezII | lld:pubmed |
pubmed-article:8976503 | pubmed:author | pubmed-author:GallowitschH... | lld:pubmed |
pubmed-article:8976503 | pubmed:author | pubmed-author:MikoschPP | lld:pubmed |
pubmed-article:8976503 | pubmed:author | pubmed-author:KresnikEE | lld:pubmed |
pubmed-article:8976503 | pubmed:author | pubmed-author:PipamWW | lld:pubmed |
pubmed-article:8976503 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8976503 | pubmed:volume | 35 | lld:pubmed |
pubmed-article:8976503 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8976503 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8976503 | pubmed:pagination | 230-5 | lld:pubmed |
pubmed-article:8976503 | pubmed:dateRevised | 2007-1-12 | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:meshHeading | pubmed-meshheading:8976503-... | lld:pubmed |
pubmed-article:8976503 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8976503 | pubmed:articleTitle | Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results. | lld:pubmed |
pubmed-article:8976503 | pubmed:affiliation | Department of Nuclear Medicine and Special Endocrinology, LKH Klagenfurt, Austria. | lld:pubmed |
pubmed-article:8976503 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8976503 | pubmed:publicationType | Comparative Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8976503 | lld:pubmed |